ArriVent BioPharma, Inc.
AVBPPharmaceutical Preparations · SIC 2834 · CIK 0001868279
Revenue FY2025
—
Net Income
$(166.0M)
EPS (Basic)
$-4.32
Net Margin
—
ROE
-54.1%
Total Equity
$307.0M
Shares Out
49M
ArriVent BioPharma, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 5 funds in our universe
Insider Transactions
Reading stored insider transactions…